These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27973472)

  • 1. In vitro and in vivo comparison between poractant alfa and the new generation synthetic surfactant CHF5633.
    Ricci F; Murgia X; Razzetti R; Pelizzi N; Salomone F
    Pediatr Res; 2017 Feb; 81(2):369-375. PubMed ID: 27973472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Surfactant CHF5633 Compared with Poractant Alfa in the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial.
    Ramanathan R; Biniwale M; Sekar K; Hanna N; Golombek S; Bhatia J; Naylor M; Fabbri L; Varoli G; Santoro D; Del Buono D; Piccinno A; Dammann CE
    J Pediatr; 2020 Oct; 225():90-96.e1. PubMed ID: 32553868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral and lung effects of a new generation synthetic surfactant with SP-B and SP-C analogs in preterm lambs.
    Rey-Santano C; Mielgo VE; Murgia X; Gomez-Solaetxe MA; Salomone F; Bianco F; Pelizzi N; Loureiro B; López de Heredia Y Goya J
    Pediatr Pulmonol; 2017 Jul; 52(7):929-938. PubMed ID: 28221717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Natural versus Synthetic Surfactant with SP-B and SP-C Analogs in a Porcine Model of Meconium Aspiration Syndrome.
    Salvesen B; Curstedt T; Mollnes TE; Saugstad OD
    Neonatology; 2014; 105(2):128-35. PubMed ID: 24356240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of synthetic surfactant CHF5633 with SP-B and SP-C analogues on lung function and inflammation in rabbit model of acute respiratory distress syndrome.
    Mikolka P; Curstedt T; Feinstein R; Larsson A; Grendar M; Rising A; Johansson J
    Physiol Rep; 2021 Jan; 9(1):e14700. PubMed ID: 33403805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SP-B and SP-C containing new synthetic surfactant for treatment of extremely immature lamb lung.
    Sato A; Ikegami M
    PLoS One; 2012; 7(7):e39392. PubMed ID: 22808033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Functional and Structural Characterization of A Synthetic Clinical Pulmonary Surfactant with Enhanced Resistance to Inhibition.
    Echaide M; Autilio C; López-Rodríguez E; Cruz A; Pérez-Gil J
    Sci Rep; 2020 Jan; 10(1):1385. PubMed ID: 31992800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of synthetic surfactant (CHF5633) bolus and/or lavage in meconium-induced lung injury in ventilated newborn rabbits.
    Xu Y; Guo X; Chen M; Ricci F; Salomone F; Murgia X; Sun B
    Pediatr Res; 2023 Feb; 93(3):541-550. PubMed ID: 35701606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome.
    Sweet DG; Turner MA; Straňák Z; Plavka R; Clarke P; Stenson BJ; Singer D; Goelz R; Fabbri L; Varoli G; Piccinno A; Santoro D; Speer CP
    Arch Dis Child Fetal Neonatal Ed; 2017 Nov; 102(6):F497-F503. PubMed ID: 28465315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Synthetic Surfactant CHF5633 Restores Lung Function and Lung Architecture in Severe Acute Respiratory Distress Syndrome in Adult Rabbits.
    Mikolka P; Kosutova P; Kolomaznik M; Nemcova N; Hanusrichterova J; Curstedt T; Johansson J; Calkovska A
    Lung; 2024 Jun; 202(3):299-315. PubMed ID: 38684519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro characterization and in vivo comparison of the pulmonary outcomes of Poractant alfa and Calsurf in ventilated preterm rabbits.
    Guo X; Luo S; Amidani D; Rivetti C; Pieraccini G; Pioselli B; Catinella S; Murgia X; Salomone F; Xu Y; Dong Y; Sun B
    PLoS One; 2020; 15(3):e0230229. PubMed ID: 32168331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.
    Fujii A; Allen R; Doros G; O'Brien S
    J Perinatol; 2010 Oct; 30(10):671-6. PubMed ID: 20336077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic surfactant CHF5633 vs poractant alfa.
    Razak A; Suresh Gautham K
    J Pediatr; 2020 Dec; 227():325-326. PubMed ID: 32798565
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
    Jeon GW; Oh M; Sin JB
    Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome.
    Fujii AM; Patel SM; Allen R; Doros G; Guo CY; Testa S
    J Perinatol; 2010 Oct; 30(10):665-70. PubMed ID: 20336076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes.
    Fehrholz M; Glaser K; Seidenspinner S; Ottensmeier B; Curstedt T; Speer CP; Kunzmann S
    PLoS One; 2016; 11(4):e0153578. PubMed ID: 27077658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the New Generation Synthetic Reconstituted Surfactant CHF5633 on Pro- and Anti-Inflammatory Cytokine Expression in Native and LPS-Stimulated Adult CD14+ Monocytes.
    Glaser K; Fehrholz M; Curstedt T; Kunzmann S; Speer CP
    PLoS One; 2016; 11(1):e0146898. PubMed ID: 26790130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic surfactant based on analogues of SP-B and SP-C is superior to single-peptide surfactants in ventilated premature rabbits.
    Almlén A; Walther FJ; Waring AJ; Robertson B; Johansson J; Curstedt T
    Neonatology; 2010 Jun; 98(1):91-9. PubMed ID: 20110733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo characterization of poractant alfa supplemented with budesonide for safe and effective intratracheal administration.
    Ricci F; Catozzi C; Ravanetti F; Murgia X; D'Aló F; Macchidani N; Sgarbi E; Di Lallo V; Saccani F; Pertile M; Cacchioli A; Catinella S; Villetti G; Civelli M; Amadei F; Stellari FF; Pioselli B; Salomone F
    Pediatr Res; 2017 Dec; 82(6):1056-1063. PubMed ID: 28723887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.